119 related articles for article (PubMed ID: 10956398)
21. Prognostic value of quantitative cytometry in a series of 415 T1T2/N0N1/M0 breast cancer patients--preliminary results.
Bolla M; Seigneurin D; Winckel P; Marron-Charrière J; Panh MH; Pasquier D; Ch-edin M; Payan R; Merlin F; Colonna M
Eur J Cancer; 1996 Sep; 32A(10):1680-5. PubMed ID: 8983274
[TBL] [Abstract][Full Text] [Related]
22. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
Formentini A; Henne-Bruns D; Kornmann M
Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
[TBL] [Abstract][Full Text] [Related]
23. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
[TBL] [Abstract][Full Text] [Related]
24. Intratumoural expression of thymidylate synthase is an independent predictor of prognosis in patients with squamous cell carcinoma of the tongue: results from a retrospective study.
Kawano K; Yanagisawa S; Kusukawa J; Sunagawa H; Shiba R; Goto M; Shinohara M; Fukuda J; Oishi M; Ikemura K; Takahashi T; Sugihara K; Inokuchi T; Mimura T; Goto H
Int J Oral Maxillofac Surg; 2006 Mar; 35(3):258-64. PubMed ID: 16280240
[TBL] [Abstract][Full Text] [Related]
25. EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols.
Span P; Heuvel J; Romain S; Piffanelli A; Martin PM; Geurts-Moespot A; Sweep F
Anticancer Res; 2000; 20(2A):681-7. PubMed ID: 10810340
[TBL] [Abstract][Full Text] [Related]
26. A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.
Niedzwiecki D; Hasson RM; Lenz HJ; Ye C; Redston M; Ogino S; Fuchs CS; Compton CC; Mayer RJ; Goldberg RM; Colacchio TA; Saltz LB; Warren RS; Bertagnolli MM
Oncologist; 2017 Jan; 22(1):107-114. PubMed ID: 27821793
[TBL] [Abstract][Full Text] [Related]
27. Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC Receptor Study Group Report.
Romain S; Spyratos F; Guirou O; Deytieux S; Chinot O; Martin PM
Eur J Cancer; 1994; 30A(14):2163-5. PubMed ID: 7857717
[TBL] [Abstract][Full Text] [Related]
28. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a,b N0 M0).
Leitner SP; Swern AS; Weinberger D; Duncan LJ; Hutter RV
Cancer; 1995 Dec; 76(11):2266-74. PubMed ID: 8635031
[TBL] [Abstract][Full Text] [Related]
29. Thymidylate synthase expression in stage II and III colon cancer: a retrospective review.
Tomiak A; Vincent M; Earle CC; Johnston PG; Kocha W; Taylor M; Maroun J; Eidus L; Whiston F; Stitt L
Am J Clin Oncol; 2001 Dec; 24(6):597-602. PubMed ID: 11801762
[TBL] [Abstract][Full Text] [Related]
30. Activities of thymidylate synthetase and thymidine kinase in gastric cancer.
Konishi T; Miyama T; Sakamoto S; Hirata T; Mafune K; Hiraishi M; Idezuki Y
Surg Oncol; 1992 Jun; 1(3):215-21. PubMed ID: 1341254
[TBL] [Abstract][Full Text] [Related]
31. The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas.
Li H; Suo Z; Zhang Y; Risberg B; Karlsson MG; Villman K; Nesland JM
Histol Histopathol; 2004 Jan; 19(1):129-36. PubMed ID: 14702180
[TBL] [Abstract][Full Text] [Related]
32. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
33. [Thymidine kinase and thymidylate synthetase activities in human gastric cancer].
Kawachi Y
Nihon Geka Gakkai Zasshi; 1993 Sep; 94(9):993-9. PubMed ID: 8246876
[TBL] [Abstract][Full Text] [Related]
34. Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
Lee SJ; Choi YL; Park YH; Kim ST; Cho EY; Ahn JS; Im YH
Cancer Chemother Pharmacol; 2011 Sep; 68(3):743-51. PubMed ID: 21170649
[TBL] [Abstract][Full Text] [Related]
35. Thymidylate synthetase and thymidine kinase activities and methotrexate cytotoxicity during growth of L1210 and Ehrlich ascites tumor.
Hullán L; Szikla K; Tusnády G; Holczinger L
Cancer Biochem Biophys; 1988 Nov; 10(2):131-9. PubMed ID: 3252959
[TBL] [Abstract][Full Text] [Related]
36. Thymidylate synthase levels as a therapeutic and prognostic predictor in breast cancer.
Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H; Fukuda M; Higuchi A; Satoh A; Mizumoto T; Hamamoto R
Anticancer Res; 1999; 19(6C):5621-6. PubMed ID: 10697629
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.
Allegra CJ; Paik S; Colangelo LH; Parr AL; Kirsch I; Kim G; Klein P; Johnston PG; Wolmark N; Wieand HS
J Clin Oncol; 2003 Jan; 21(2):241-50. PubMed ID: 12525515
[TBL] [Abstract][Full Text] [Related]
38. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
Toi M; Ikeda T; Akiyama F; Kurosumi M; Tsuda H; Sakamoto G; Abe O
Int J Oncol; 2007 Oct; 31(4):899-906. PubMed ID: 17786323
[TBL] [Abstract][Full Text] [Related]
39. Thymidylate synthase gene polymorphism predicts disease free survival in stage II-III rectal adenocarcinoma patients receiving adjuvant 5-FU-based chemotherapy.
Su X; Li S; Zhang H; Xiao H; Chen C; Wang G
Chin Clin Oncol; 2019 Jun; 8(3):28. PubMed ID: 30823845
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.
Etienne MC; Chazal M; Laurent-Puig P; Magné N; Rosty C; Formento JL; Francoual M; Formento P; Renée N; Chamorey E; Bourgeon A; Seitz JF; Delpero JR; Letoublon C; Pezet D; Milano G
J Clin Oncol; 2002 Jun; 20(12):2832-43. PubMed ID: 12065560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]